AmplifiX Releases Comprehensive Sector Report on the Rapid Acceleration of Real-World Asset (RWA) Tokenization 
KaJ Labs Pushes Next Phase of AI-Driven Web3 Innovation Through Platform Integration 
Uproot Clean Introduces Enzyme-Based Washing Machine Cleaner Designed for Pet Households 
Voices of Liberty Podcast Launches with Strong Popularity on Apple Podcasts in the United States 
Titan Logix Corp. Reports Q1 Fiscal 2026 Financial Results ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update
Lead program ORIC-101 on track for two initial Phase 1b data readouts in 2021 Three…
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Paltusotine Phase 3 PATHFNDR program in acromegaly initiated in 2Q 2021 Phase 1 data for…
Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights
– On Track to Report Initial Phase 2 Data From pheNIX PKU Clinical Trial by…
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
VRDN-001 and VRDN-002 programs for Thyroid Eye Disease (TED) progressing; on track for IND filings…
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH at Upcoming Medical Conferences
COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Recro Reports First Quarter 2021 Financial Results
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple…
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021
Reports Net Revenues of $103.0 Million for the Three Months Ended March 31, 2021 RANCHO…
Codexis Reports First Quarter 2021 Financial Results
Total Revenue up 23% and Product Revenue Doubles Year over Year REDWOOD CITY, Calif., May…
Tricida Announces First Quarter 2021 Financial Results
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE)…
T2 Biosystems Announces First Quarter 2021 Financial Results
LEXINGTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Assembly Biosciences Reports First Quarter 2021 Financial Results and Recent Updates
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
Calithera Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights
–$102.9 Million in Cash and Investments at March 31, 2021– — Conference Call and Webcast…
SIGA Reports Financial Results for Three Months Ended March 31, 2021
– Approximately $3 Million in International Sales of Oral TPOXX® in the First Quarter –…
NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results
Expect to report topline data from Phase 2b ALPINE 2/3 clinical trial of aldafermin in…
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today provided…
Caladrius Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
Conference call begins today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J. , May 06,…
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
Conference Call and Webcast at 5:00 pm Eastern Time THE WOODLANDS, Texas, May 06, 2021…
Vaxcyte to Present at BofA Securities 2021 Health Care Conference
FOSTER CITY, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
Tarsus Pharmaceuticals, Inc. Initiates Saturn-2, Second Pivotal Phase 3 Trial Evaluating the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Demodex blepharitis may affect up to 25 million Americans and result in significant clinical, functional…
Kura Oncology Reports First Quarter 2021 Financial Results
– Menin inhibitor KO-539 continues to demonstrate compelling clinical activity, favorable safety/tolerability and a wide…